Cargando…
Topical nystatin prophylaxis: a likely viable measure for reducing impact of candidemia in neurosurgical patients with early tracheostomy intubation
Autores principales: | Ceccarelli, Giancarlo, Giuliano, Simone, Falcone, Marco, Venditti, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056660/ https://www.ncbi.nlm.nih.gov/pubmed/23414732 http://dx.doi.org/10.1186/cc11921 |
Ejemplares similares
-
Oral Nystatin Versus Intravenous Fluconazole as Neonatal Antifungal Prophylaxis: Non-inferiority Trial
por: Mersal, Ali, et al.
Publicado: (2013) -
Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial
por: Giglio, Mariateresa, et al.
Publicado: (2012) -
Comparison of Conventional Surgical Tracheostomy and Percutaneous Dilatational Tracheostomy in the Neurosurgical Intensive Care Unit
por: Lim, Sungdae, et al.
Publicado: (2022) -
Accessing Nystatin through Mariculture
por: La Clair, James J.
Publicado: (2021) -
Impact of nystatin on Candida and the oral microbiome
por: Hingston, Christopher D, et al.
Publicado: (2012)